Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Concentration-Response Modeling of ECG Data From Early-Phase Clinical Studies as an Alternative Clinical and Regulatory Approach to Assessing QT Risk - Experience From the Development Program of Lemborexant.
Murphy PJ, Yasuda S, Nakai K, Yoshinaga T, Hall N, Zhou M, Aluri J, Rege B, Moline M, Ferry J, Darpo B. Murphy PJ, et al. Among authors: moline m. J Clin Pharmacol. 2017 Jan;57(1):96-104. doi: 10.1002/jcph.785. Epub 2016 Aug 4. J Clin Pharmacol. 2017. PMID: 27338807 Clinical Trial.
Temporary insanity and premenstrual syndrome.
Severino SK, Moline M. Severino SK, et al. Among authors: moline m. N Y State J Med. 1989 Feb;89(2):94-5. N Y State J Med. 1989. PMID: 2710443 No abstract available.
Sex differences in circadian control of LH secretion.
Albers HE, Moline ML, Moore-Ede MC. Albers HE, et al. Among authors: moline ml. J Endocrinol. 1984 Jan;100(1):101-5. doi: 10.1677/joe.0.1000101. J Endocrinol. 1984. PMID: 6690643
Circadian rhythms and photoperiodism.
Moore-Ede MC, Moline ML. Moore-Ede MC, et al. Among authors: moline ml. Ciba Found Symp. 1985;117:23-37. doi: 10.1002/9780470720981.ch3. Ciba Found Symp. 1985. PMID: 3836815
Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study.
Murphy P, Moline M, Mayleben D, Rosenberg R, Zammit G, Pinner K, Dhadda S, Hong Q, Giorgi L, Satlin A. Murphy P, et al. Among authors: moline m. J Clin Sleep Med. 2017 Nov 15;13(11):1289-1299. doi: 10.5664/jcsm.6800. J Clin Sleep Med. 2017. PMID: 29065953 Free PMC article. Clinical Trial.
Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
Rosenberg R, Murphy P, Zammit G, Mayleben D, Kumar D, Dhadda S, Filippov G, LoPresti A, Moline M. Rosenberg R, et al. Among authors: moline m. JAMA Netw Open. 2019 Dec 2;2(12):e1918254. doi: 10.1001/jamanetworkopen.2019.18254. JAMA Netw Open. 2019. PMID: 31880796 Free PMC article. Clinical Trial.
Safety of lemborexant versus placebo and zolpidem: effects on auditory awakening threshold, postural stability, and cognitive performance in healthy older participants in the middle of the night and upon morning awakening.
Murphy P, Kumar D, Zammit G, Rosenberg R, Moline M. Murphy P, et al. Among authors: moline m. J Clin Sleep Med. 2020 May 15;16(5):765-773. doi: 10.5664/jcsm.8294. Epub 2020 Feb 6. J Clin Sleep Med. 2020. PMID: 32022664 Free PMC article. Clinical Trial.
167 results